Added to YB: 2025-11-07
Pitch date: 2025-10-31
NIOX.L [neutral]
NIOX Group Plc
+2.28%
current return
Author Info
Increasing Odds shares their investment journey in their newsletter. Sign up for the newsletter.
Company Info
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide.
Market Cap
GBP 269.4M
Pitch Price
GBP 0.66
Price Target
N/A
Dividend
2.42%
EV/EBITDA
16.92
P/E
39.03
EV/Sales
5.14
Sector
Health Care Equipment and Supplies
Category
growth
AIM A-Z Part 22: Buybacks, NAV Discounts, Quality Medtech and Solid Drinks - Pass: Niox Group (Ticker: NIOX)
NIOX.L pass: £88M medtech co making asthma/COPD diagnostics. H1: 20% revenue growth, 30% adj EBITDA growth to £9.2M. 70% recurring consumables revenue, 20% research/trials. Turned profitable 2023, debt-free, £5M dividend + £21M tender. 23x fwd P/E too rich despite quality fundamentals.
Read full article (1 min)